XML 16 R7.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Operating activities    
Net loss $ (145,879) $ (69,639)
Adjustments to reconcile net loss to net cash used in operating activities:    
Gain on sale of ATOM Facility 0 (50,237)
Stock-based compensation expense 24,316 28,452
Depreciation and amortization expense 2,415 3,029
Accretion of liability related to sale of future revenues 2,456 0
Amortization (accretion) of investment premiums (discounts) (1,106) 811
Non-cash operating lease expense 5,827 3,355
Other non-cash items, net 100 46
Changes in operating assets and liabilities:    
Accounts receivable 39,714 349
Inventories (6,275) 0
Prepaid expenses and other current assets 169 (1,546)
Other assets (110) 76
Accounts payable (2,780) (3,384)
Accrued compensation (5,103) (8,833)
Accrued research and development expenses (4,255) 1,674
Other current liabilities 3,685 2,891
Deferred revenue 2,514 (51,468)
Operating lease liabilities (7,021) (4,211)
Other long-term liabilities 108 142
Net cash used in operating activities (91,225) (148,493)
Investing activities    
Purchases of short-term investments (83,647) (165,090)
Proceeds from maturities and sales of short-term investments 128,020 166,390
Purchases of property and equipment (898) (4,024)
Net proceeds from sale of ATOM Facility 0 94,765
Net cash (used in) provided by investing activities 43,475 92,041
Financing activities    
Proceeds from issuance of common stock through ATM facilities, net 590 20,516
Proceeds from employee stock awards 747 1,405
Taxes paid related to net share settlement of restricted stock units (94) (619)
Principal payments on finance lease obligations (524) (190)
Other financing activities, net (13) (104)
Net cash provided by financing activities 706 21,008
Decrease in cash, cash equivalents and restricted cash (47,044) (35,444)
Cash, cash equivalents and restricted cash at beginning of period 93,088 107,478
Cash, cash equivalents and restricted cash at end of period 46,044 72,034
Non-cash investing and financing activities    
Property and equipment purchases included in accounts payable and other accrued liabilities 108 132
Supplemental cash flow disclosure    
Cash paid for interest 218 133
Cash paid for income taxes $ 2 $ 19